Business Context and Reporting Period
This Form 8-K Current Report from Merit Medical Systems, Inc. (MMSI) covers events occurring on May 13, 2026, and May 14, 2026. The filing details the outcomes of the Company's 2026 Annual Meeting of Shareholders and subsequent Board actions regarding corporate governance and equity plans.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance, shareholder voting results, and the adoption of new equity incentive plans.
Material Changes and Corporate Actions
- Equity Plan Approvals: Shareholders approved the 2026 Equity Incentive Plan (EIP) and the 2026 Employee Stock Purchase Plan (ESPP). The Board subsequently approved a base form Restricted Stock Unit (RSU) Award Agreement for directors, vesting after 350 days of continuous service.
- Bylaw Amendments: On May 14, 2026, the Board adopted the Fifth Amended and Restated Bylaws. Key updates include clarifying remote participation for shareholders and directors, permitting electronic notice delivery, updating universal proxy rules, and modifying officer composition and indemnification provisions to align with the Utah Revised Business Corporation Act.
- Director Elections: Shareholders elected Martha G. Aronson, Lonny J. Carpenter, and Scott R. Ward to three-year terms, and Lynne N. Ward to a one-year term.
Shareholder Voting Results and Management Commentary
Of the 59,648,292 shares entitled to vote, 52,532,073 shares were represented at the Annual Meeting. All five proposals submitted to shareholders were approved:
- Proposal 1 (Election of Directors): All four nominees received majority support. Scott R. Ward received the highest "For" vote count (50,071,431), while Lonny J. Carpenter received the highest "Against" vote count (1,206,492).
- Proposal 2 (Say-on-Pay): The advisory vote on executive compensation passed with 48,835,995 votes "For" and 1,415,355 votes "Against."
- Proposal 3 (2026 EIP): Approved with 48,750,003 votes "For" and 1,510,844 votes "Against."
- Proposal 4 (2026 ESPP): Approved with 50,109,861 votes "For" and 151,208 votes "Against."
- Proposal 5 (Auditor Ratification): Deloitte & Touche LLP was ratified with 50,369,058 votes "For" and 2,151,392 votes "Against."
Investor Verification Checklist
- Verify the specific terms and share limits of the newly approved 2026 Equity Incentive Plan and Employee Stock Purchase Plan in the attached Exhibits 10.1 and 10.2.
- Review the Fifth Amended and Restated Bylaws (Exhibit 3.1) to understand changes to remote meeting participation and indemnification obligations.
- Confirm the vesting schedule and service requirements for the new Director RSU Agreement (Exhibit 10.3).
- Note that the filing does not provide updated financial guidance or operational metrics; refer to the most recent 10-K or 10-Q for financial status.